Everly Bio

Transforming fertility care with a multi-system, non-invasive, AI-driven approach that enhances outcomes and accessibility.

HealthTech
Active
Pre-Seed Jerusalem, Israel Founded 2022
Last updated 2026-09-06
Total raised
$1.7M
Last: Undisclosed Round 2025-03
Stage
Pre-Seed
Founded
2022
Headcount
4
HQ
Jerusalem, Israel
Sector
HealthTech

About

Everly Bio is a computational biology process company focused on decision-support in fertility care. The company utilizes deep molecular data to develop standardized diagnostics, improve implementation success rates, and identify novel biological interventions. This enables IVF clinics, fertility specialists, and couples to make informed decisions, maximize success rates, and minimize the emotional and financial toll associated with infertility treatments. They target molecular markers for successful implantation in reproductive fluids, taking a holistic approach to the fertility journey. Everly Bio's technology forms the foundation for a medical device that delivers rapid results, integrated with an app that continuously collects and analyzes clinical data. Everly Bio aims to revolutionize the methodology of infertility treatments, enabling shorter time to pregnancy, increasing accessibility.

Funding history · 1 round · $1.7M total

1 event/round · $1.7M Total Funding: $1.7M in Private Equity
Jan 2023
Undisclosed Round $1.7M pitchbook.com
★ Yissum★ VLX VenturesRimon Investment Fund

Headcount over time

4 employees (2026-09) · 1 point
4 4 2026-09

Offices

Jerusalem, Israel · HQ / main office

Q&A

What is Everly Bio's primary focus?
Everly Bio focuses on fertility care, utilizing novel multisystem molecular insights and advanced computational biology to provide decision support in fertility treatments.
When was Everly Bio founded?
Everly Bio was founded in March 2023.
How many employees does Everly Bio currently have?
Everly Bio has 1-10 employees.
What is Everly Bio's total funding to date?
Everly Bio has raised a total of $1,700,000 USD.
What is the current funding stage of Everly Bio?
Everly Bio is currently in the Pre-Seed funding stage.
Who are the co-founders of Everly Bio?
The co-founders of Everly Bio are Michal Gilon Ohev-zion, who also serves as CEO, and Noam Shomron.
What technologies does Everly Bio utilize in its solutions?
Everly Bio utilizes Biologicals and Artificial Intelligence in its solutions.
What business models does Everly Bio employ?
Everly Bio operates with both B2C and B2B business models.

Team · 3

Michal Gilon Ohev-Zion
Founder · Co-founder
Noam Shomron
Founder · Co-founder
Moran Ben David Shapira
CEO

Sectors & technology

Primary sector
HealthTech
Technologies
Target customers
Business model
B2CB2B

Highlights

Verified

Tags

healthcarefertilityartificial-intelligencemachine-learningfemtech
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteeverly.bio
LinkedInlinkedin.com/company/everly-bio

Identifiers & details

Founded2022
Employees (exact)4

Radar intelligence

Web history (Wayback)

Domaineverly.bio

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516695822
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-10-24
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events12 — annual_report (6), violation (1), people (3), shares_capital (2)
Registered addressפרופ רקח 1 ירושלים

Recent registry events

DateEvent
2025-09-30דו~ח שנתי-עדכון מען דיגיטלי
2025-09-30דו~ח שנתי-עדכון בעלי מניות
2025-09-30דו~ח שנתי-הוספת בעל תפקיד
2025-09-30דו~ח שנתי-שינוי בהוראות בתקנון
2025-09-30דו~ח שנתי-הקצאת מניות
2025-09-30דו~ח שנתי-הוספת דירקטור
2025-09-30עדכון הפרה
2026-03-30עדכון דירקטורים-הסרת דירקטור
2026-03-30עדכון דירקטורים-הוספת דירקטור
2026-07-20הקצאת מניות
2025-09-10עדכון בעלי תפקידים
2026-08-03שינוי בהרכב הון - מניות-הפחתת הון מוקצה